{"schema_version":"secwatch.filing_event.v1","accession":"0001568651-23-000043","form_type":"8-K","ticker":"OSCR","cik":"0001568651","company_name":"Oscar Health, Inc.","filed_at":"2023-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.374729+00:00","generated_at":"2026-06-12T01:54:53.897847+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Oscar Health Q2 2023: net loss narrows to $15.4M; Adj EBITDA turns positive at $35.6M; CFO Blackley appointed","bullets":["Net loss of $15.4M improved $96.7M YoY; Adjusted EBITDA $35.6M vs -$75.8M YoY.","MLR improved 230 bps YoY to 79.9%; InsuranceCo Combined Ratio improved 500 bps to 96.7%.","Premiums earned $1.5B (+48% YoY); Direct and Assumed Policy Premiums $1.6B (-3% YoY).","Full-year 2023 guidance tightened: MLR towards low-end of 82-84%, Adj EBITDA towards high-end of -$175M to -$75M.","R. Scott Blackley returns as CFO effective Aug 14; Sid Sankaran steps down but stays on Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001568651-23-000043","json":"https://secwatch.observer/filing/0001568651-23-000043.json","markdown":"https://secwatch.observer/filing/0001568651-23-000043.md","text":"https://secwatch.observer/filing/0001568651-23-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/0001568651-23-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/oscr-20230802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T01:54:53.897847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fbd9859bc88d287602ba25e044058d9906cfb8ba","claim":"Oscar Health, Inc. updated its full year 2023 guidance (reaffirmed).","evidence_excerpt":"Oscar is reaffirming its full year 2023 outlook across all metrics as provided in its financial results press release dated February 9, 2023, with MLR now projected to be towards the low-end of the 82% - 84% range and Adjusted EBITDA 1 projected to be towards the high-end of the ($175) million - ($75) million range, towards a ($75) million loss.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/0001568651-23-000043-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"5d0e5af94e","claim":"R. Scott Blackley changed role as Chief Financial Officer at Oscar Health, Inc..","evidence_excerpt":"Effective August 14, 2023, R. Scott Blackley will become the Company’s Chief Financial Officer (“CFO”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/0001568651-23-000043-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will become"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"f942c3b22e","claim":"Siddhartha Sankaran departed as Chief Financial Officer at Oscar Health, Inc..","evidence_excerpt":"Mr. Siddhartha Sankaran will remain CFO through that date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/0001568651-23-000043-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}